GNBT - Generex Biotechnology Corporation

Other OTC - Other OTC Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue---
Cost of Revenue---
Gross Profit---
Operating Expenses
Research Development422.294467.3821,185.384
Selling General and Administrative1,174.5471,435.1862,377.53
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-1,596.841-1,902.568-3,562.914
Income from Continuing Operations
Total Other Income/Expenses Net-74,492.657-902.0411,719.584
Earnings Before Interest and Taxes-76,089.498-2,804.609-1,843.33
Interest Expense743.101418.5350.028
Income Before Tax-76,832.599-3,223.109-2,193.358
Income Tax Expense---
Minority Interest-5,518.465-5,518.465-5,518.465
Net Income From Continuing Ops-70,016.194-3,223.109-2,193.358
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-70,016.194-3,223.109-2,193.358
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-70,016.194-3,223.109-2,532.941